10:29 AM EST - Spectral Medical Inc. : Announced that Health Canada has issued an Interim Order expanding the already approved indications for use of Spectral’s Toraymyxin™ (“PMX”) hemoperfusion cartridge specifically for patients with COVID-19. As part of the Interim Order process, the Health Minister determined that there is an urgent public health need for the importation or sale of PMX. Spectral and its manufacturing partner, collectively applied for the authorization for the Interim Order. Spectral Medical Inc.
shares T.EDT are trading up $0.07 at $0.74.
